4CMenB vaccination shows sterilizing activity when its primary indication of invasive meningococcal disease is considered; however, given the hypothesized cross-protective immunity against Ng and previous evidence of partial efficacy, protection is likely to be limited and prone to failure in the case of substantial exposure to Ng. The gene discussed is NRGN; the disease is meningococcal infection.